Armie Margaret Lee is a reporter covering private equity. Previously, she was at InvestmentWires, an online media company that focuses on the mutual fund and 401(k) industries. She has also covered real estate and banking for Miami Today and technology for Manila Times in the Philippines.
Recent Articles By The Author
Mylan Shares Surge as Analyst Says It's Poised to Gain Share From Rivals
Morgan Stanley analyst David Risinger is upbeat about the drugmaker's generic drug growth prospects in the U.S.
Pressure May Be On Allergan to Strike a Major Deal, As Botox Gets Another Rival
Mylan and Revance Therapeutics say they have teamed up to develop and commercialize a proposed biosimilar or copy of Allergan's popular Botox, potentially ratcheting up pressure on the drugmaker.
Mylan Shares Jump After Earnings Beat
The pharmaceutical company unveiled a collaboration and license pact with Revance Therapeutics to develop and commercialize a proposed biosimilar or copy of Allergan's Botox.
Celgene Shares Tank on Multiple Sclerosis Drug Application Setback
The Food and Drug Administration determined that the nonclinical and clinical pharmacology sections in the new drug application "were insufficient to permit a complete review," Celgene said.
Apple Preps to Launch Health Clinics for Employees
The news from the tech giant comes a month after Amazon, Berkshire Hathaway and JPMorgan unveiled a joint healthcare initiative.